Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,105 | 339 | 93.5% |
| Education | $354.33 | 8 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| HARMONY BIOSCIENCES LLC | $721.91 | 44 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $709.82 | 42 | $0 (2024) |
| GlaxoSmithKline, LLC. | $423.92 | 37 | $0 (2022) |
| Genentech USA, Inc. | $420.95 | 43 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $361.12 | 21 | $0 (2024) |
| Grifols USA, LLC | $330.68 | 19 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $321.48 | 20 | $0 (2023) |
| United Therapeutics Corporation | $287.76 | 13 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $253.75 | 16 | $0 (2024) |
| Amgen Inc. | $162.21 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,031 | 58 | HARMONY BIOSCIENCES LLC ($292.90) |
| 2023 | $1,130 | 62 | Harmony Biosciences LLC ($375.40) |
| 2022 | $625.90 | 32 | Pulmonx Corporation ($85.46) |
| 2021 | $359.57 | 23 | JAZZ PHARMACEUTICALS INC. ($82.05) |
| 2020 | $236.66 | 14 | CSL Behring ($60.65) |
| 2019 | $510.28 | 47 | Genentech USA, Inc. ($109.67) |
| 2018 | $568.81 | 46 | GlaxoSmithKline, LLC. ($141.32) |
| 2017 | $996.85 | 65 | Boehringer Ingelheim Pharmaceuticals, Inc. ($207.33) |
All Payment Transactions
347 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $20.15 | General |
| Category: Narcoplepsy | ||||||
| 12/06/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Neurology | ||||||
| 11/14/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: NEUROLOGY | ||||||
| 11/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Pulmonology | ||||||
| 11/08/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $17.46 | General |
| Category: Narcoplepsy | ||||||
| 11/01/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 10/25/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/21/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $14.38 | General |
| Category: Narcoplepsy | ||||||
| 10/18/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Pulmonology | ||||||
| 10/17/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $20.94 | General |
| 10/07/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $22.32 | General |
| Category: Narcoplepsy | ||||||
| 10/04/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Respiratory | ||||||
| 09/20/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $23.66 | General |
| Category: Narcoplepsy | ||||||
| 09/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Pulmonology | ||||||
| 09/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/06/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $16.82 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: RESPIRATORY | ||||||
| 08/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Respiratory | ||||||
| 08/23/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $12.31 | General |
| Category: Narcoplepsy | ||||||
| 08/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Immunology | ||||||
| 08/21/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $4.06 | General |
| Category: Narcoplepsy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,014 | 2,342 | $438,214 | $115,787 |
| 2022 | 13 | 1,909 | 2,246 | $414,673 | $115,362 |
| 2021 | 16 | 1,913 | 2,296 | $408,195 | $123,849 |
| 2020 | 17 | 1,573 | 2,028 | $418,623 | $117,631 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 240 | 345 | $95,220 | $31,090 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 279 | 323 | $78,489 | $20,469 | 26.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 101 | 101 | $42,420 | $11,809 | 27.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 57 | 124 | $23,188 | $7,248 | 31.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 248 | 264 | $23,320 | $6,296 | 27.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 240 | 255 | $23,613 | $6,277 | 26.6% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 144 | 144 | $35,962 | $5,966 | 16.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 255 | 271 | $27,700 | $4,754 | 17.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 49 | 59 | $16,284 | $4,264 | 26.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 53 | 53 | $14,522 | $4,109 | 28.3% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 28 | 31 | $11,160 | $2,840 | 25.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 23 | 23 | $8,280 | $2,017 | 24.4% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 73 | 81 | $7,615 | $1,747 | 22.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $6,018 | $1,629 | 27.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 31 | 32 | $7,776 | $1,565 | 20.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 15 | 15 | $6,300 | $1,470 | 23.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 85 | 107 | $7,704 | $1,431 | 18.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 65 | 86 | $2,236 | $722.40 | 32.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 11 | 11 | $407.00 | $83.87 | 20.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 253 | 377 | $99,103 | $34,404 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 265 | 321 | $58,366 | $20,317 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 108 | 108 | $43,200 | $12,589 | 29.1% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 187 | 188 | $62,603 | $10,365 | 16.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 173 | 184 | $20,700 | $6,052 | 29.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 170 | 179 | $19,812 | $5,532 | 27.9% |
About Dr. Gary Koenig, MD
Dr. Gary Koenig, MD is a Internal Medicine healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1942204656.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Koenig, MD has received a total of $5,459 in payments from pharmaceutical and medical device companies, with $1,031 received in 2024. These payments were reported across 347 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($5,105).
As a Medicare-enrolled provider, Koenig has provided services to 7,409 Medicare beneficiaries, totaling 8,912 services with total Medicare billing of $472,630. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Allergy & Immunology, Pulmonary Disease
- Location Omaha, NE
- Active Since 06/09/2005
- Last Updated 08/22/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1942204656
Products in Payments
- WAKIX (Drug) $668.30
- OFEV (Drug) $450.95
- Prolastin-C Liquid (Biological) $251.92
- NUCALA (Biological) $240.53
- Esbriet (Biological) $218.35
- Xolair (Biological) $202.60
- FASENRA (Biological) $167.48
- OPSUMIT MACITENTAN (Drug) $152.97
- XYWAV (Drug) $152.64
- GLASSIA (Biological) $145.23
- Adempas (Drug) $139.69
- TEZSPIRE (Biological) $137.43
- DUPIXENT (Biological) $122.33
- WatchPAT (Device) $114.62
- BREZTRI (Drug) $98.50
- OPSUMIT (Drug) $97.74
- BREO (Drug) $90.64
- Arikayce (Drug) $87.08
- CHARTIS CATHETER (Device) $85.46
- Zemaira (Biological) $85.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Omaha
Mojtaba Akhtari, M.d, M.D
Internal Medicine — Payments: $1.6M
Dr. Matthew Lunning, D.o, D.O
Internal Medicine — Payments: $650,808
Michael Dunn, M.d, M.D
Internal Medicine — Payments: $221,491
Dr. Brian Boer, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $96,162
Dr. Trevor Van Schooneveld, M.d, M.D
Internal Medicine — Payments: $91,007
Dr. Michael Schafer, Md, MD
Internal Medicine — Payments: $60,335